nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—hypertension—metabolic syndrome X	0.839	1	CtDrD
Bepridil—CALM1—sympathetic nervous system—metabolic syndrome X	0.00463	0.0956	CbGeAlD
Bepridil—Emotional distress—Metformin—metabolic syndrome X	0.00332	0.132	CcSEcCtD
Bepridil—CALM1—autonomic nervous system—metabolic syndrome X	0.00311	0.0643	CbGeAlD
Bepridil—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.0024	0.0952	CcSEcCtD
Bepridil—TNNC1—cardiovascular system—metabolic syndrome X	0.0018	0.0372	CbGeAlD
Bepridil—CALM2—artery—metabolic syndrome X	0.00177	0.0366	CbGeAlD
Bepridil—CALM1—artery—metabolic syndrome X	0.00176	0.0364	CbGeAlD
Bepridil—PDE1B—adipose tissue—metabolic syndrome X	0.00166	0.0342	CbGeAlD
Bepridil—TNNC1—adipose tissue—metabolic syndrome X	0.00159	0.0328	CbGeAlD
Bepridil—PDE1A—cardiovascular system—metabolic syndrome X	0.00157	0.0325	CbGeAlD
Bepridil—PDE1A—kidney—metabolic syndrome X	0.00154	0.0318	CbGeAlD
Bepridil—CALM2—endothelium—metabolic syndrome X	0.0015	0.0309	CbGeAlD
Bepridil—CALM1—endothelium—metabolic syndrome X	0.00149	0.0308	CbGeAlD
Bepridil—KCNQ1—cardiovascular system—metabolic syndrome X	0.00146	0.0302	CbGeAlD
Bepridil—KCNQ1—kidney—metabolic syndrome X	0.00143	0.0296	CbGeAlD
Bepridil—PDE1A—adipose tissue—metabolic syndrome X	0.00139	0.0287	CbGeAlD
Bepridil—CALM2—blood vessel—metabolic syndrome X	0.00138	0.0285	CbGeAlD
Bepridil—CALM1—blood vessel—metabolic syndrome X	0.00137	0.0284	CbGeAlD
Bepridil—KCNQ1—adipose tissue—metabolic syndrome X	0.00129	0.0267	CbGeAlD
Bepridil—CACNA1H—cardiovascular system—metabolic syndrome X	0.00123	0.0254	CbGeAlD
Bepridil—CACNA1D—cardiovascular system—metabolic syndrome X	0.00101	0.021	CbGeAlD
Bepridil—PDE1A—liver—metabolic syndrome X	0.000973	0.0201	CbGeAlD
Bepridil—Liver function test abnormal—Metformin—metabolic syndrome X	0.000945	0.0375	CcSEcCtD
Bepridil—CACNA1C—cardiovascular system—metabolic syndrome X	0.000936	0.0193	CbGeAlD
Bepridil—KCNQ1—liver—metabolic syndrome X	0.000905	0.0187	CbGeAlD
Bepridil—Influenza—Metformin—metabolic syndrome X	0.000885	0.0351	CcSEcCtD
Bepridil—Angina pectoris—Metformin—metabolic syndrome X	0.000862	0.0342	CcSEcCtD
Bepridil—Abdominal discomfort—Metformin—metabolic syndrome X	0.000849	0.0337	CcSEcCtD
Bepridil—CACNA1C—adipose tissue—metabolic syndrome X	0.000825	0.0171	CbGeAlD
Bepridil—Drowsiness—Metformin—metabolic syndrome X	0.000789	0.0313	CcSEcCtD
Bepridil—CACNA1H—liver—metabolic syndrome X	0.00076	0.0157	CbGeAlD
Bepridil—Bradycardia—Metformin—metabolic syndrome X	0.000721	0.0286	CcSEcCtD
Bepridil—Rhinitis—Metformin—metabolic syndrome X	0.00071	0.0282	CcSEcCtD
Bepridil—ATP1A1—cardiovascular system—metabolic syndrome X	0.000699	0.0144	CbGeAlD
Bepridil—CALM3—adipose tissue—metabolic syndrome X	0.000691	0.0143	CbGeAlD
Bepridil—ATP1A1—kidney—metabolic syndrome X	0.000684	0.0141	CbGeAlD
Bepridil—Cardiac disorder—Metformin—metabolic syndrome X	0.000658	0.0261	CcSEcCtD
Bepridil—CACNA1D—liver—metabolic syndrome X	0.000627	0.013	CbGeAlD
Bepridil—ATP1A1—adipose tissue—metabolic syndrome X	0.000616	0.0127	CbGeAlD
Bepridil—CALM2—cardiovascular system—metabolic syndrome X	0.000616	0.0127	CbGeAlD
Bepridil—CALM1—cardiovascular system—metabolic syndrome X	0.000613	0.0127	CbGeAlD
Bepridil—Flatulence—Metformin—metabolic syndrome X	0.000608	0.0241	CcSEcCtD
Bepridil—CALM2—kidney—metabolic syndrome X	0.000602	0.0124	CbGeAlD
Bepridil—CALM1—kidney—metabolic syndrome X	0.0006	0.0124	CbGeAlD
Bepridil—Vision blurred—Metformin—metabolic syndrome X	0.000581	0.0231	CcSEcCtD
Bepridil—Tremor—Metformin—metabolic syndrome X	0.000578	0.0229	CcSEcCtD
Bepridil—KCNH2—cardiovascular system—metabolic syndrome X	0.000558	0.0115	CbGeAlD
Bepridil—Syncope—Metformin—metabolic syndrome X	0.000553	0.0219	CcSEcCtD
Bepridil—ABCB1—blood vessel—metabolic syndrome X	0.000548	0.0113	CbGeAlD
Bepridil—Palpitations—Metformin—metabolic syndrome X	0.000545	0.0216	CcSEcCtD
Bepridil—CALM2—adipose tissue—metabolic syndrome X	0.000543	0.0112	CbGeAlD
Bepridil—Loss of consciousness—Metformin—metabolic syndrome X	0.000542	0.0215	CcSEcCtD
Bepridil—CALM1—adipose tissue—metabolic syndrome X	0.00054	0.0112	CbGeAlD
Bepridil—Hypertension—Metformin—metabolic syndrome X	0.000532	0.0211	CcSEcCtD
Bepridil—Myalgia—Metformin—metabolic syndrome X	0.000525	0.0208	CcSEcCtD
Bepridil—Oedema—Metformin—metabolic syndrome X	0.000503	0.02	CcSEcCtD
Bepridil—Shock—Metformin—metabolic syndrome X	0.000495	0.0196	CcSEcCtD
Bepridil—Hyperhidrosis—Metformin—metabolic syndrome X	0.000487	0.0193	CcSEcCtD
Bepridil—CALM3—liver—metabolic syndrome X	0.000485	0.01	CbGeAlD
Bepridil—Anorexia—Metformin—metabolic syndrome X	0.00048	0.019	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000459	0.0182	CcSEcCtD
Bepridil—Paraesthesia—Metformin—metabolic syndrome X	0.000452	0.0179	CcSEcCtD
Bepridil—Dyspnoea—Metformin—metabolic syndrome X	0.000449	0.0178	CcSEcCtD
Bepridil—Somnolence—Metformin—metabolic syndrome X	0.000447	0.0177	CcSEcCtD
Bepridil—Dyspepsia—Metformin—metabolic syndrome X	0.000443	0.0176	CcSEcCtD
Bepridil—Decreased appetite—Metformin—metabolic syndrome X	0.000438	0.0174	CcSEcCtD
Bepridil—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000435	0.0172	CcSEcCtD
Bepridil—ATP1A1—liver—metabolic syndrome X	0.000432	0.00893	CbGeAlD
Bepridil—Constipation—Metformin—metabolic syndrome X	0.00043	0.0171	CcSEcCtD
Bepridil—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000412	0.0163	CcSEcCtD
Bepridil—Abdominal pain—Metformin—metabolic syndrome X	0.000398	0.0158	CcSEcCtD
Bepridil—CALM2—liver—metabolic syndrome X	0.000381	0.00787	CbGeAlD
Bepridil—CALM1—liver—metabolic syndrome X	0.000379	0.00783	CbGeAlD
Bepridil—Asthenia—Metformin—metabolic syndrome X	0.000361	0.0143	CcSEcCtD
Bepridil—Diarrhoea—Metformin—metabolic syndrome X	0.000344	0.0137	CcSEcCtD
Bepridil—Dizziness—Metformin—metabolic syndrome X	0.000333	0.0132	CcSEcCtD
Bepridil—CYP2D6—kidney—metabolic syndrome X	0.000333	0.00688	CbGeAlD
Bepridil—Rash—Metformin—metabolic syndrome X	0.000317	0.0126	CcSEcCtD
Bepridil—Dermatitis—Metformin—metabolic syndrome X	0.000317	0.0126	CcSEcCtD
Bepridil—Headache—Metformin—metabolic syndrome X	0.000315	0.0125	CcSEcCtD
Bepridil—Nausea—Metformin—metabolic syndrome X	0.000299	0.0119	CcSEcCtD
Bepridil—ABCB1—cardiovascular system—metabolic syndrome X	0.000245	0.00506	CbGeAlD
Bepridil—ABCB1—kidney—metabolic syndrome X	0.000239	0.00495	CbGeAlD
Bepridil—ABCB1—adipose tissue—metabolic syndrome X	0.000216	0.00446	CbGeAlD
Bepridil—CYP2D6—liver—metabolic syndrome X	0.00021	0.00435	CbGeAlD
Bepridil—ABCB1—liver—metabolic syndrome X	0.000151	0.00313	CbGeAlD
Bepridil—CALM1—Signaling by GPCR—AGT—metabolic syndrome X	8.48e-06	9.69e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AGT—metabolic syndrome X	8.48e-06	9.69e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—LIPC—metabolic syndrome X	8.47e-06	9.68e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GCK—metabolic syndrome X	8.47e-06	9.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GHRL—metabolic syndrome X	8.44e-06	9.64e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOC3—metabolic syndrome X	8.42e-06	9.62e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—LPL—metabolic syndrome X	8.36e-06	9.55e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—LPL—metabolic syndrome X	8.36e-06	9.55e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CYBA—metabolic syndrome X	8.34e-06	9.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CYBA—metabolic syndrome X	8.34e-06	9.52e-05	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—AKT1—metabolic syndrome X	8.32e-06	9.5e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SCARB1—metabolic syndrome X	8.31e-06	9.49e-05	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.22e-06	9.39e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CETP—metabolic syndrome X	8.18e-06	9.34e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GHRL—metabolic syndrome X	8.16e-06	9.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GHRL—metabolic syndrome X	8.16e-06	9.32e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.16e-06	9.32e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—AKT1—metabolic syndrome X	8.14e-06	9.29e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—metabolic syndrome X	8.09e-06	9.24e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—metabolic syndrome X	8.08e-06	9.23e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SREBF1—metabolic syndrome X	8.07e-06	9.21e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CRP—metabolic syndrome X	8.02e-06	9.16e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CNR1—metabolic syndrome X	7.99e-06	9.13e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—AKT1—metabolic syndrome X	7.87e-06	8.99e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—AKT1—metabolic syndrome X	7.87e-06	8.99e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HMGCR—metabolic syndrome X	7.85e-06	8.96e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GOT2—metabolic syndrome X	7.85e-06	8.96e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	7.83e-06	8.94e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CRP—metabolic syndrome X	7.76e-06	8.86e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CRP—metabolic syndrome X	7.76e-06	8.86e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CNR1—metabolic syndrome X	7.73e-06	8.83e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CNR1—metabolic syndrome X	7.73e-06	8.83e-05	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.69e-06	8.79e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	7.6e-06	8.68e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOB—metabolic syndrome X	7.58e-06	8.66e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—AKT1—metabolic syndrome X	7.49e-06	8.56e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—AKT1—metabolic syndrome X	7.46e-06	8.52e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—metabolic syndrome X	7.46e-06	8.52e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—AKT1—metabolic syndrome X	7.45e-06	8.51e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TGFB1—metabolic syndrome X	7.42e-06	8.47e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	7.39e-06	8.45e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GOT2—metabolic syndrome X	7.39e-06	8.45e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—metabolic syndrome X	7.39e-06	8.44e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PLA2G4A—metabolic syndrome X	7.38e-06	8.43e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOB—metabolic syndrome X	7.34e-06	8.38e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOB—metabolic syndrome X	7.34e-06	8.38e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—AKT1—metabolic syndrome X	7.25e-06	8.28e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—AKT1—metabolic syndrome X	7.25e-06	8.28e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—APOE—metabolic syndrome X	7.25e-06	8.28e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—LPL—metabolic syndrome X	7.24e-06	8.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCL2—metabolic syndrome X	7.22e-06	8.25e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TGFB1—metabolic syndrome X	7.17e-06	8.19e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TGFB1—metabolic syndrome X	7.17e-06	8.19e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—APOA1—metabolic syndrome X	7.16e-06	8.18e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PLA2G4A—metabolic syndrome X	7.14e-06	8.15e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PLA2G4A—metabolic syndrome X	7.14e-06	8.15e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—APOE—metabolic syndrome X	7.01e-06	8.01e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—APOE—metabolic syndrome X	7.01e-06	8.01e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—LPL—metabolic syndrome X	7e-06	8e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—LPL—metabolic syndrome X	7e-06	8e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRS1—metabolic syndrome X	7e-06	8e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ABCA1—metabolic syndrome X	6.99e-06	7.99e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	6.99e-06	7.99e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCL2—metabolic syndrome X	6.99e-06	7.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCL2—metabolic syndrome X	6.99e-06	7.98e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.93e-06	7.92e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—APOA1—metabolic syndrome X	6.93e-06	7.92e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—APOA1—metabolic syndrome X	6.93e-06	7.92e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—AKT1—metabolic syndrome X	6.88e-06	7.86e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CD36—metabolic syndrome X	6.88e-06	7.86e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—metabolic syndrome X	6.82e-06	7.79e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—AKT1—metabolic syndrome X	6.82e-06	7.79e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRS1—metabolic syndrome X	6.77e-06	7.74e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRS1—metabolic syndrome X	6.77e-06	7.74e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GOT1—metabolic syndrome X	6.77e-06	7.74e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GGT1—metabolic syndrome X	6.77e-06	7.74e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CD36—metabolic syndrome X	6.66e-06	7.6e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CD36—metabolic syndrome X	6.66e-06	7.6e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	6.59e-06	7.53e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	6.59e-06	7.53e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF2—metabolic syndrome X	6.53e-06	7.46e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IRS1—metabolic syndrome X	6.47e-06	7.38e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARA—metabolic syndrome X	6.4e-06	7.31e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GOT1—metabolic syndrome X	6.38e-06	7.29e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GGT1—metabolic syndrome X	6.38e-06	7.29e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—metabolic syndrome X	6.34e-06	7.24e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOB—metabolic syndrome X	6.34e-06	7.24e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF2—metabolic syndrome X	6.32e-06	7.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF2—metabolic syndrome X	6.32e-06	7.22e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—AKT1—metabolic syndrome X	6.3e-06	7.19e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IRS1—metabolic syndrome X	6.25e-06	7.14e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IRS1—metabolic syndrome X	6.25e-06	7.14e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AGT—metabolic syndrome X	6.19e-06	7.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL5—metabolic syndrome X	6.19e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—INS—metabolic syndrome X	6.19e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARA—metabolic syndrome X	6.19e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARA—metabolic syndrome X	6.19e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.17e-06	7.05e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOB—metabolic syndrome X	6.13e-06	7.01e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOB—metabolic syndrome X	6.13e-06	7.01e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOE—metabolic syndrome X	6.07e-06	6.93e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LPL—metabolic syndrome X	6.05e-06	6.92e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOA1—metabolic syndrome X	6e-06	6.85e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AGT—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AGT—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL5—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL5—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—INS—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—INS—metabolic syndrome X	5.99e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	5.97e-06	6.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	5.97e-06	6.82e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOE—metabolic syndrome X	5.87e-06	6.71e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOE—metabolic syndrome X	5.87e-06	6.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LPL—metabolic syndrome X	5.86e-06	6.69e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LPL—metabolic syndrome X	5.86e-06	6.69e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOA1—metabolic syndrome X	5.8e-06	6.63e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOA1—metabolic syndrome X	5.8e-06	6.63e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOB—metabolic syndrome X	5.75e-06	6.56e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SERPINE1—metabolic syndrome X	5.69e-06	6.5e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	5.59e-06	6.39e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SERPINE1—metabolic syndrome X	5.5e-06	6.28e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SERPINE1—metabolic syndrome X	5.5e-06	6.28e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—LPL—metabolic syndrome X	5.49e-06	6.27e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—metabolic syndrome X	5.43e-06	6.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOB—metabolic syndrome X	5.42e-06	6.19e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—metabolic syndrome X	5.4e-06	6.17e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—metabolic syndrome X	5.29e-06	6.04e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	5.27e-06	6.02e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—metabolic syndrome X	5.25e-06	6e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—metabolic syndrome X	5.25e-06	6e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—metabolic syndrome X	5.22e-06	5.97e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CD36—metabolic syndrome X	5.21e-06	5.96e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—INS—metabolic syndrome X	5.19e-06	5.92e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGT—metabolic syndrome X	5.18e-06	5.92e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.17e-06	5.91e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—metabolic syndrome X	5.16e-06	5.89e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—metabolic syndrome X	5.11e-06	5.84e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—metabolic syndrome X	5.11e-06	5.84e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—metabolic syndrome X	5.08e-06	5.8e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOE—metabolic syndrome X	5.08e-06	5.8e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—metabolic syndrome X	5.03e-06	5.75e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOA1—metabolic syndrome X	5.02e-06	5.73e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—INS—metabolic syndrome X	5.02e-06	5.73e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—INS—metabolic syndrome X	5.02e-06	5.73e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGT—metabolic syndrome X	5.01e-06	5.72e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGT—metabolic syndrome X	5.01e-06	5.72e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—metabolic syndrome X	4.99e-06	5.7e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—metabolic syndrome X	4.99e-06	5.7e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—metabolic syndrome X	4.97e-06	5.67e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CD36—metabolic syndrome X	4.91e-06	5.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOE—metabolic syndrome X	4.91e-06	5.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—metabolic syndrome X	4.91e-06	5.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOE—metabolic syndrome X	4.91e-06	5.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—metabolic syndrome X	4.91e-06	5.61e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—metabolic syndrome X	4.87e-06	5.56e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—metabolic syndrome X	4.87e-06	5.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOA1—metabolic syndrome X	4.85e-06	5.54e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOA1—metabolic syndrome X	4.85e-06	5.54e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARA—metabolic syndrome X	4.85e-06	5.54e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—metabolic syndrome X	4.82e-06	5.51e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—metabolic syndrome X	4.8e-06	5.49e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—metabolic syndrome X	4.8e-06	5.49e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—metabolic syndrome X	4.78e-06	5.46e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—metabolic syndrome X	4.75e-06	5.43e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—metabolic syndrome X	4.74e-06	5.42e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AGT—metabolic syndrome X	4.69e-06	5.36e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—metabolic syndrome X	4.64e-06	5.3e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOE—metabolic syndrome X	4.6e-06	5.25e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—metabolic syndrome X	4.6e-06	5.25e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—metabolic syndrome X	4.6e-06	5.25e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARA—metabolic syndrome X	4.57e-06	5.22e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—metabolic syndrome X	4.55e-06	5.19e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.55e-06	5.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS1—metabolic syndrome X	4.53e-06	5.17e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—metabolic syndrome X	4.49e-06	5.13e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—metabolic syndrome X	4.49e-06	5.13e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—metabolic syndrome X	4.46e-06	5.09e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AGT—metabolic syndrome X	4.42e-06	5.05e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—metabolic syndrome X	4.41e-06	5.04e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—metabolic syndrome X	4.4e-06	5.02e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—metabolic syndrome X	4.4e-06	5.02e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS1—metabolic syndrome X	4.38e-06	5e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS1—metabolic syndrome X	4.38e-06	5e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—metabolic syndrome X	4.34e-06	4.95e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOE—metabolic syndrome X	4.33e-06	4.95e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—metabolic syndrome X	4.31e-06	4.92e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—metabolic syndrome X	4.31e-06	4.92e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.29e-06	4.89e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL2—metabolic syndrome X	4.27e-06	4.87e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—metabolic syndrome X	4.19e-06	4.79e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—metabolic syndrome X	4.19e-06	4.79e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—metabolic syndrome X	4.19e-06	4.79e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—metabolic syndrome X	4.16e-06	4.75e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL2—metabolic syndrome X	4.13e-06	4.71e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL2—metabolic syndrome X	4.13e-06	4.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—metabolic syndrome X	4.06e-06	4.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—metabolic syndrome X	4.06e-06	4.63e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—metabolic syndrome X	4.02e-06	4.6e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—metabolic syndrome X	4.02e-06	4.6e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.01e-06	4.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—metabolic syndrome X	3.98e-06	4.55e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—metabolic syndrome X	3.93e-06	4.49e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—metabolic syndrome X	3.85e-06	4.4e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—metabolic syndrome X	3.85e-06	4.4e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—metabolic syndrome X	3.8e-06	4.34e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—metabolic syndrome X	3.78e-06	4.31e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—metabolic syndrome X	3.7e-06	4.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—metabolic syndrome X	3.68e-06	4.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—metabolic syndrome X	3.68e-06	4.2e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—metabolic syndrome X	3.6e-06	4.11e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—metabolic syndrome X	3.59e-06	4.1e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—metabolic syndrome X	3.47e-06	3.97e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—metabolic syndrome X	3.47e-06	3.97e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.45e-06	3.94e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.39e-06	3.88e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.25e-06	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—metabolic syndrome X	3.21e-06	3.66e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.15e-06	3.6e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—metabolic syndrome X	3.1e-06	3.54e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—metabolic syndrome X	3.1e-06	3.54e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.97e-06	3.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—metabolic syndrome X	2.96e-06	3.38e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—metabolic syndrome X	2.93e-06	3.35e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—metabolic syndrome X	2.86e-06	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—metabolic syndrome X	2.86e-06	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—metabolic syndrome X	2.83e-06	3.24e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—metabolic syndrome X	2.83e-06	3.24e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—metabolic syndrome X	2.71e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—metabolic syndrome X	2.7e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—metabolic syndrome X	2.62e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—metabolic syndrome X	2.62e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—metabolic syndrome X	2.62e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—metabolic syndrome X	2.62e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—metabolic syndrome X	2.51e-06	2.87e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—metabolic syndrome X	2.5e-06	2.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—metabolic syndrome X	2.43e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—metabolic syndrome X	2.43e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—metabolic syndrome X	2.41e-06	2.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—metabolic syndrome X	2.41e-06	2.76e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—metabolic syndrome X	2.09e-06	2.39e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—metabolic syndrome X	2.02e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—metabolic syndrome X	2.02e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—metabolic syndrome X	1.89e-06	2.16e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—metabolic syndrome X	1.83e-06	2.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—metabolic syndrome X	1.83e-06	2.09e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—metabolic syndrome X	1.75e-06	2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—metabolic syndrome X	1.69e-06	1.93e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—metabolic syndrome X	1.69e-06	1.93e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.58e-06	1.81e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.49e-06	1.71e-05	CbGpPWpGaD
